REGULAXIS SAS
Regulaxis mission is to grant licenses of innovative molecules after phase II clinical records.
REGULAXIS SAS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-12-01
Address:
Romainville, Ile-de-France, France
Country:
France
Website Url:
http://www.regulaxis.com
Total Employee:
1+
Status:
Active
Contact:
+33660904124
Email Addresses:
[email protected]
Total Funding:
3.21 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Regulaxis SAS
Newest Events participated
Official Site Inspections
http://www.regulaxis.com Semrush global rank: 5.59 M Semrush visits lastest month: 581
- Host name: 81.88.48.95
- IP address: 81.88.48.95
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Regulaxis SAS"
REGULAXIS a French Innovative Biotechnology Company
REGULAXIS a French Innovative Biotechnology Company. Based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules …See details»
Regulaxis SAS - LinkedIn
REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, …See details»
Regulaxis SAS - Crunchbase Company Profile & Funding
When was the last funding round for Regulaxis SAS? Regulaxis SAS closed its last funding round on Jul 30, 2018 from a Angel round. Who are Regulaxis SAS 's competitors? Alternatives and …See details»
Regulaxis - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 Regulaxis is a funded company based in Romainville (France), founded in 2013 by Claude Carelli. It operates as a French Biopharma R&D company working on synthetic drugs …See details»
Regulaxis Company Profile - Office Locations, Competitors ... - Craft
Regulaxis is a biotechnology company that is engaged in the research, development, and licensing of synthetic molecules for use in human treatments. It provides therapies based on …See details»
REGULAXIS Company Profile | ROMAINVILLE, ILE DE ... - Dun
Find company research, competitor information, contact details & financial data for REGULAXIS of ROMAINVILLE, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
Regulaxis - VentureRadar
REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic …See details»
About us - Regulaxis
Regulaxis SAS is a biotech company created in 2013 by Claude Carelli to develop innovative therapies for human clinic based on new synthetic peptides regulating cell growth and …See details»
REGULAXIS (ROMAINVILLE) Chiffre d'affaires, résultat, bilans sur ...
Jan 2, 2020 REGULAXIS, société par actions simplifiée, au capital social de 1096750,00 EURO, dont le siège social est situé au 102 AV GASTON ROUSSEL, 93230 ROMAINVILLE, …See details»
Regulaxis SAS: A French startup that develops ... - KoreaTechDesk
Apr 28, 2021 The scope of regenerative treatments in the medical sector is growing with new methods and innovative solutions. French startup Regulaxis SAS is a biotech company that …See details»
Regulaxis SAS - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Team - Regulaxis
Laboratory Parc scientifique Biocitech 102 Avenue Gaston Roussel Batiment Pasteur Secteur 2169 93230 Romainville - France Office 56 Boulevard de la Mission Marchand - 92400 …See details»
Regulaxis CEO and Key Executive Team | Craft.co
Regulaxis's President & CEO is Claude Carelli. Other executives include Christelle Vêtu, COO; Matthieu Chareyre, Executive Director Industrial Operations. See the full leadership team at …See details»
Contact Page | Regulaxis
Laboratory Parc scientifique Biocitech 102 Avenue Gaston Roussel Batiment Pasteur Secteur 2169 93230 Romainville - France Office 56 Boulevard de la Mission Marchand - 92400 …See details»
Regulaxis SAS - Contacts, Employees, Board Members
Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs. New. Resources. Advanced Search. ... Log In. …See details»
R&D - Regulaxis
Regulaxis is engaged in the R&D of molecules that can advantageously be proposed to treat. Reconstitution and repair of articular cartilage by stimulation of chondrocytes, cartilage-forming …See details»
☑️Regulaxis SAS — Consulting Organization from
Regulaxis SAS — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Science & Innovation sectorSee details»
Regulaxis' new drug for OA therapy is raising interest - LinkedIn
Jan 10, 2018 Regulaxis SAS, develops new peptides acting on cell signaling for regenerative medicine, becomes a champion within the EC H2020 program Apr 21, 2017See details»
SEC Charges PGI Global Founder with $198 Million Crypto Asset …
Apr 22, 2025 The Securities and Exchange Commission today charged Ramil Palafox for orchestrating a fraudulent scheme that raised approximately $198 million from investors …See details»
Regulaxis SAS, develops new peptides acting on cell ... - LinkedIn
Apr 21, 2017 Regulaxis SAS, a French biotech, receives a €2.1 million grant from EU under the Horizon2020/SME Instrument Phase 2 program for its project RYHP: A new hope for early …See details»